Xiang Li

Xiang Li

2015-2016

Affiliations

State University of New York

Technologies

Pharmaceutical Drug

Therapeutic

Indication

Personalized Medicine

Regenerative Medicine

Surgical Tool

We have developed and patented a novel preservation solution to be used as a clinical treatment for ischemia-reperfusion injury in organ transplantation, particularly intestinal transplantation

Newsletter Signup

Corporate Supporters